表紙
市場調查報告書
商品編碼
1030704

全球分子診斷市場——2028 年的行業趨勢和預測

Global Molecular Diagnostics Market - Industry Trends and Forecast to 2028

出版日期: | 出版商: Data Bridge Market Research Private Limited | 英文 476 Pages | 商品交期: 請詢問到貨日

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2021 年至 2028 年,全球分子診斷市場預計將以 6.0% 的複合年增長率增長。市場上的增長因素包括對用於診斷 COVID-19 的分子診斷的需求不斷增加以及患有各種疾病的患者人數增加。

本報告調查了全球分子診斷市場,包括市場增長和抑制因素、機遇和挑戰、COVID-19 的影響、按產品、技術、應用、最終用戶和地區進行的市場分析。它提供了競爭條件等信息和主要公司的簡介。

目錄

第 1 章介紹

第 2 章市場細分

第 3 章執行摘要

第 4 章重要考慮事項

  • 產品和品牌分析:全球分子診斷市場
  • 人工智能和機器學習在全球分子診斷市場中的作用

第 5 章市場概覽

  • 增長因素
    • 對用於診斷 COVID-19 的分子診斷工具的需求不斷增加
    • 傳染病和癌症的患病率增加
    • 增加對分子診斷產品的資助
    • 對即時 (POC) 檢測的需求不斷增加
    • 伴隨診斷檢測和個性化藥物開發
  • 抑制因素
    • 儀器成本高
    • 嚴格的法律和監管標準
    • 延遲批准分子診斷實驗性試驗
  • 市場機會
    • 老年人口增加
    • 越來越多地採用分析儀軟件進行分子診斷
    • 提高對快速技術進步的認識
    • 社區醫療保健的醫療費用增加
  • 挑戰
    • 市場競爭者之間的激烈競爭
    • COVID-19 又一次供應鏈中斷

第 6 章全球 COVID-19 對全球分子診斷市場的影響

  • 全球 COVID-19 對全球分子診斷市場的影響分析
  • COVID-19 的後果和政府為發展分子診斷市場所做的努力
  • 對需求的影響
  • 對供應鏈的影響
  • 對價格的影響
  • 製造商的戰略舉措
  • COVID-19 越來越多的病例推動了分子診斷市場
  • 結論

第 7 章按產品分類:全球分子診斷市場

  • 概述
  • 設備
    • 全自動設備
    • 半自動裝置
  • 試劑和試劑盒
  • 服務和軟件

第 8 章按技術:全球分子診斷市場

  • 概述
  • 基於聚合□鍊式反應 (PCR) 的方法
    • 實時 PCR
    • 數位 PCR
    • 逆轉錄□ PCR
    • 定量螢光 PCR
    • 直接線性分析
    • 冷 PCR
  • 下一代序列 (NGS)
  • 細胞遺傳學
  • 毛細管電泳
  • 原位雜交(ISH 或 FISH)
  • 分子成像
    • 光學成像
    • FDG-PET
  • 質譜 (MS)
  • 芯片和微陣列
  • 其他

第 9 章按應用:全球分子診斷市場

  • 概述
  • 傳染病
  • 微生物學
  • 血液篩查
  • 腫瘤學
  • 組織類型判斷
  • 藥理學基因組學
  • 產前檢測
  • 神經系統疾病
  • 心血管疾病
  • 其他

第 10 章按最終用戶:全球分子診斷市場

  • 概述
  • 臨床實驗室
  • 醫院
  • 學術

第 11 章區域:全球分子診斷市場

  • 世界市場
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 馬來西亞
    • 泰國
    • 印度尼西亞
    • 新加坡
    • 菲律賓
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 意大利
    • 俄羅斯
    • 英國
    • 西班牙
    • 土耳其
    • 瑞士
    • 比利時
    • 荷蘭
    • 其他
  • 中東和非洲
    • 南非
    • 其他

第 12 章全球分子診斷市場:企業現狀

  • 公司股票分析:世界
  • 公司股票分析:北美
  • 公司股票分析:歐洲
  • 公司股票分析:亞太地區

第 13 章 SWOT

第 14 章公司簡介

  • ABBOTT LABORATORIES
  • F. HOFFMANN-LA ROCHE LTD
  • ILLUMINA, INC.
  • HOLOGIC, INC.
  • BIOMERIEUX SA
  • AGILENT TECHNOLOGIES, INC.
  • BD
  • BECKMAN COULTER, INC.
  • BIO-RAD LABORATORIES, INC.
  • CEPHEID
  • GENMARK DIAGNOSTICS, INC.
  • IMMUCOR
  • LIFE TECHNOLOGIES
  • LUMINEX CORPORATION
  • MERRIDIAN BIOSCIENCE
  • MYRIAD GENETICS, INC.
  • QIAGEN
  • QUIDEL CORPORATION
  • SIEMENS HEALTHCARE GMBH
  • THERMO FISHER SCIENTIFIC INC

第 15 章問卷

第 16 章相關報導

目錄

Global Molecular Diagnostics Market is projected to register a CAGR of 6.0% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

Global Molecular Diagnostics Market, By Products (Reagents & Kits, Instruments and Services & Softwares), Technology (Mass Spectrometry (MS), Capillary Electrophoresis, Next Generation Sequencing (NGS), Chips And Microarray, Polymerase Chain Reaction (PCR)-Based Methods, Cytogenetics, In Situ Hybridization (ISH or FISH), Molecular Imaging and Others), Application (Oncology, Pharmacogenomics, Microbiology, Prenatal Tests, Tissue Typing, Blood Screening, Cardiovascular Diseases, Neurological Diseases, Infectious Diseases and Others), End User (Hospital, Clinical Laboratories and Academics), Country (U.S., Canada, Mexico, Germany, France, Spain, Turkey, U.K., Netherlands, Russia, Switzerland, Belgium, Italy and Rest Of Europe, China, India, Japan, Australia, South Korea, Malaysia, Singapore, Thailand, Indonesia, Philippines, Rest Of Asia-Pacific, Brazil, and Rest Of South America, South Africa, and Rest Of Middle East and Africa) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the global molecular diagnostics market are:

  • Increasing demand for molecular diagnostics to diagnose COVID-19.
  • Rising number of patients with various illness

Market Players:

The key market players for Global Molecular Diagnostics Market are listed below:

  • Abbott
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • BD
  • bioMerieux SA
  • Cepheid
  • Hologic, Inc.
  • Life Technologies
  • Myriad Genetics, Inc.
  • QIAGEN
  • Agilent Technologies, Inc.
  • Quidel Corporation
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • IMMUCOR
  • Luminex Corporation
  • Meridian Bioscience
  • Hoffmann-La Roche Ltd
  • GenMark Diagnostics, Inc.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL MOLECULAR DIAGNOSTICS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 MULTIVARIATE MODELLING
  • 2.8 PRODUCT LIFELINE CURVE
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PRODUCT AND BRAND ANALYSIS: GLOBAL MOLECULAR DIAGNOSTICS MARKET
  • 4.2 ROLE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN GLOBAL MOLECULAR DIAGNOSTICS MARKET

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 RISING DEMAND FOR MOLECULAR DIAGNOSTIC TOOLS TO DIAGNOSE COVID-19
    • 5.1.2 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER
    • 5.1.3 RISING FUNDING FOR MOLECULAR DIAGNOSIS PRODUCTS
    • 5.1.4 RISING DEMAND FOR POINT-OF-CARE (POC) TESTING
    • 5.1.5 DEVELOPMENT OF COMPANION DIAGNOSTIC ASSAY AND PERSONALIZED MEDICINES
  • 5.2 RESTRAINTS
    • 5.2.1 HIGH COST OF INSTRUMENTATIONS
    • 5.2.2 STRINGENT LEGAL AND REGULATORY STANDARDS ARE EXPECTED TO HAMPER THE MARKET GROWTH
    • 5.2.3 DELAY IN APPROVAL OF EXPERIMENTAL TEST FOR MOLECULAR DIAGNOSIS
  • 5.3 OPPORTUNITIES
    • 5.3.1 RISING GERIATRIC POPULATION
    • 5.3.2 INCREASING ADOPTION OF ANALYSER SOFTWARE FOR MOLECULAR DIAGNOSIS
    • 5.3.3 RISING AWARENESS REGARDING RAPID TECHNOLOGICAL ADVANCEMENTS
    • 5.3.4 RISING HEALTHCARE EXPENDITURE IN DEVELOPING REGION
  • 1.4 CHALLENGES
    • 5.3.5 HIGH COMPETITION AMONG MARKET PLAYERS
    • 5.3.6 DISTURBED SUPPLY CHAIN DUE TO COVID-19

6 IMPACT OF COVID-19 ON THE GLOBAL MOLECULAR DIAGNOSTICS MARKET

  • 6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE GLOBAL MOLECULAR DIAGNOSTICS MARKET
  • 6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVES FOR GROWTH OF THE MOLECULAR DIAGNOSTICS MARKET
  • 6.3 IMPACT ON DEMAND
  • 6.4 IMPACT ON SUPPLY CHAIN
  • 6.5 IMPACT ON PRICE
  • 6.6 STRATEGIC INITIATIVES BY MANUFACTURERS
  • 6.7 THE RISING COVID-19 CASES IS LEADING THE MOLECULAR DIAGNOSTICS MARKET
  • 6.8 CONCLUSION

7 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT

  • 7.1 OVERVIEW
  • 7.2 INSTRUMENTS
    • 7.2.1 FULLY AUTOMATED INSTRUMENTS
    • 7.2.2 SEMI-AUTOMATED INSTRUMENTS
  • 7.3 REAGENTS AND KITS
  • 7.4 SERVICES AND SOFTWARES

8 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 8.1 OVERVIEW
  • 8.2 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 8.2.1 REAL-TIME PCR
    • 8.2.2 DIGITAL PCR
    • 8.2.3 REVERSE TRANSCRIPTASE PCR
    • 8.2.4 QUANTITATIVE FLUORESCENT PCR
    • 8.2.5 DIRECT LINEAR ANALYSIS
    • 8.2.6 COLD PCR
  • 8.3 NEXT GENERATION SEQUENCING (NGS)
  • 8.4 CYTOGENETICS
  • 8.5 CAPILLARY ELECTROPHORESIS
  • 8.6 IN SITU HYBRIDIZATION (ISH OR FISH)
  • 8.7 MOLECULAR IMAGING
    • 8.7.1 OPTICAL IMAGING
    • 8.7.2 FDG-PET
  • 8.8 MASS SPECTROMETRY (MS)
  • 8.9 CHIPS AND MICROARRAY
  • 8.10 OTHERS

9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 INFECTIOUS DISEASES
    • 9.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.2.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.2.3 CYTOGENETICS
    • 9.2.4 CAPILLARY ELECTROPHORESIS
    • 9.2.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.2.6 MOLECULAR IMAGING
    • 9.2.7 MASS SPECTROMETRY (MS)
    • 9.2.8 CHIPS AND MICROARRAY
    • 9.2.9 OTHERS
  • 9.3 MICROBIOLOGY
    • 9.3.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.3.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.3.3 CYTOGENETICS
    • 9.3.4 CAPILLARY ELECTROPHORESIS
    • 9.3.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.3.6 MOLECULAR IMAGING
    • 9.3.7 MASS SPECTROMETRY (MS)
    • 9.3.8 CHIPS AND MICROARRAY
    • 9.3.9 OTHERS
  • 9.4 BLOOD SCREENING
    • 9.4.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.4.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.4.3 CYTOGENETICS
    • 9.4.4 CAPILLARY ELECTROPHORESIS
    • 9.4.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.4.6 MOLECULAR IMAGING
    • 9.4.7 MASS SPECTROMETRY (MS)
    • 9.4.8 CHIPS AND MICROARRAY
    • 9.4.9 OTHERS
  • 9.5 ONCOLOGY
    • 9.5.1 ONCOLOGY, BY CANCER TYPE
      • 9.5.1.1 BREAST CANCER
      • 9.5.1.2 COLORECTAL CANCER
      • 9.5.1.3 LUNG CANCER
      • 9.5.1.4 PROSTATE CANCER
      • 9.5.1.5 OTHERS
    • 9.5.2 ONCOLOGY, BY TECHNOLOGY
      • 9.5.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
      • 9.5.2.2 NEXT GENERATION SEQUENCING (NGS)
      • 9.5.2.3 CYTOGENETICS
      • 9.5.2.4 CAPILLARY ELECTROPHORESIS
      • 9.5.2.5 IN SITU HYBRIDIZATION (ISH OR FISH)
      • 9.5.2.6 MOLECULAR IMAGING
      • 9.5.2.7 MASS SPECTROMETRY (MS)
      • 9.5.2.8 CHIPS AND MICROARRAY
      • 9.5.2.9 OTHERS
  • 9.6 TISSUE TYPING
    • 9.6.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.6.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.6.3 CYTOGENETICS
    • 9.6.4 CAPILLARY ELECTROPHORESIS
    • 9.6.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.6.6 MOLECULAR IMAGING
    • 9.6.7 MASS SPECTROMETRY (MS)
    • 9.6.8 CHIPS AND MICROARRAY
    • 9.6.9 OTHERS
  • 9.7 PHARMACOGENOMICS
    • 9.7.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.7.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.7.3 CYTOGENETICS
    • 9.7.4 CAPILLARY ELECTROPHORESIS
    • 9.7.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.7.6 MOLECULAR IMAGING
    • 9.7.7 MASS SPECTROMETRY (MS)
    • 9.7.8 CHIPS AND MICROARRAY
    • 9.7.9 OTHERS
  • 9.8 PRENATAL TESTS
    • 9.8.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.8.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.8.3 CYTOGENETICS
    • 9.8.4 CAPILLARY ELECTROPHORESIS
    • 9.8.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.8.6 MOLECULAR IMAGING
    • 9.8.7 MASS SPECTROMETRY (MS)
    • 9.8.8 CHIPS AND MICROARRAY
    • 9.8.9 OTHERS
  • 9.9 NEUROLOGICAL DISEASES
    • 9.9.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.9.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.9.3 CYTOGENETICS
    • 9.9.4 CAPILLARY ELECTROPHORESIS
    • 9.9.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.9.6 MOLECULAR IMAGING
    • 9.9.7 MASS SPECTROMETRY (MS)
    • 9.9.8 CHIPS AND MICROARRAY
    • 9.9.9 OTHERS
  • 9.10 CARDIOVASCULAR DISEASES
    • 9.10.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.10.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.10.3 CYTOGENETICS
    • 9.10.4 CAPILLARY ELECTROPHORESIS
    • 9.10.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.10.6 MOLECULAR IMAGING
    • 9.10.7 MASS SPECTROMETRY (MS)
    • 9.10.8 CHIPS AND MICROARRAY
    • 9.10.9 OTHERS
  • 9.11 OTHERS
    • 9.11.1 POLYMERASE CHAIN REACTION (PCR)-BASED METHODS
    • 9.11.2 NEXT GENERATION SEQUENCING (NGS)
    • 9.11.3 CYTOGENETICS
    • 9.11.4 CAPILLARY ELECTROPHORESIS
    • 9.11.5 IN SITU HYBRIDIZATION (ISH OR FISH)
    • 9.11.6 MOLECULAR IMAGING
    • 9.11.7 MASS SPECTROMETRY (MS)
    • 9.11.8 CHIPS AND MICROARRAY
    • 9.11.9 OTHERS

10 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 CLINICAL LABORATORIES
  • 10.3 HOSPITAL
  • 10.4 ACADEMICS

11 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION

  • 11.1 GLOBAL MARKET
  • 11.2 NORTH AMERICA
    • 11.2.1 U.S.
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 SOUTH AMERICA
    • 11.3.1 BRAZIL
    • 11.3.2 REST OF SOUTH AMERICA
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 JAPAN
    • 11.4.3 INDIA
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 MALAYSIA
    • 11.4.7 THAILAND
    • 11.4.8 INDONESIA
    • 11.4.9 SINGAPORE
    • 11.4.10 PHILIPPINES
    • 11.4.11 REST OF ASIA-PACIFIC
  • 11.5 EUROPE
    • 11.5.1 GERMANY
    • 11.5.2 FRANCE
    • 11.5.3 ITALY
    • 11.5.4 RUSSIA
    • 11.5.5 U.K.
    • 11.5.6 SPAIN
    • 11.5.7 TURKEY
    • 11.5.8 SWITZERLAND
    • 11.5.9 BELGIUM
    • 11.5.10 NETHERLANDS
    • 11.5.11 REST OF EUROPE
  • 11.6 MIDDLE EAST AND AFRICA
    • 11.6.1 SOUTH AFRICA
    • 11.6.2 REST OF MIDDLE EAST AND AFRICA

12 GLOBAL MOLECULAR DIAGNOSTICS MARKET: COMPANY LANDSCAPE

  • 12.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 12.3 COMPANY SHARE ANALYSIS: EUROPE
  • 12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT

14 COMPANY PROFILES

  • 14.1 ABBOTT LABORATORIES
    • 14.1.1 COMPANY SNAPSHOT
    • 14.1.2 REVENUE ANALYSIS
    • 14.1.3 COMPANY SHARE ANALYSIS
    • 14.1.4 PRODUCT PORTFOLIO
    • 14.1.5 RECENT DEVELOPMENTS
  • 14.2 F. HOFFMANN-LA ROCHE LTD
    • 14.2.1 COMPANY SNAPSHOT
    • 14.2.2 REVENUE ANALYSIS
    • 14.2.3 COMPANY SHARE ANALYSIS
    • 14.2.4 PRODUCT PORTFOLIO
    • 14.2.5 RECENT DEVELOPMENTS
  • 14.3 ILLUMINA, INC.
    • 14.3.1 COMPANY SNAPSHOT
    • 14.3.2 REVENUE ANALYSIS
    • 14.3.3 COMPANY SHARE ANALYSIS
    • 14.3.4 PRODUCT PORTFOLIO
    • 14.3.5 RECENT DEVELOPMENTS
  • 14.4 HOLOGIC, INC.
    • 14.4.1 COMPANY SNAPSHOT
    • 14.4.2 REVENUE ANALYSIS
    • 14.4.3 COMPANY SHARE ANALYSIS
    • 14.4.4 PRODUCT PORTFOLIO
    • 14.4.5 RECENT DEVELOPMENTS
  • 14.5 BIOMERIEUX SA
    • 14.5.1 COMPANY SNAPSHOT
    • 14.5.2 COMPANY SHARE ANALYSIS
    • 14.5.3 REVENUE ANALYSIS
    • 14.5.4 PRODUCT PORTFOLIO
    • 14.5.5 RECENT DEVELOPMENT
  • 14.6 AGILENT TECHNOLOGIES, INC.
    • 14.6.1 COMPANY SNAPSHOT
    • 14.6.2 REVENUE ANALYSIS
    • 14.6.3 PRODUCT PORTFOLIO
    • 14.6.4 RECENT DEVELOPMENTS
  • 14.7 BD
    • 14.7.1 COMPANY SNAPSHOT
    • 14.7.2 REVENUE ANALYSIS
    • 14.7.3 PRODUCT PORTFOLIO
    • 14.7.4 RECENT DEVELOPMENTS
  • 14.8 BECKMAN COULTER, INC.
    • 14.8.1 COMPANY SNAPSHOT
    • 14.8.2 PRODUCT PORTFOLIO
    • 14.8.3 RECENT DEVELOPMENTS
  • 14.9 BIO-RAD LABORATORIES, INC.
    • 14.9.1 COMPANY SNAPSHOT
    • 14.9.2 REVENUE ANALYSIS
    • 14.9.3 PRODUCT PORTFOLIO
    • 14.9.4 RECENT DEVELOPMENTS
  • 14.10 CEPHEID
    • 14.10.1 COMPANY SNAPSHOT
    • 14.10.2 PRODUCT PORTFOLIO
    • 14.10.3 RECENT DEVELOPMENTS
  • 14.11 GENMARK DIAGNOSTICS, INC.
    • 14.11.1 COMPANY SNAPSHOT
    • 14.11.2 PRODUCT PORTFOLIO
    • 14.11.3 RECENT DEVELOPMENT
  • 14.12 IMMUCOR
    • 14.12.1 COMPANY SNAPSHOT
    • 14.12.2 PRODUCT PORTFOLIO
    • 14.12.3 RECENT DEVELOPMENT
  • 14.13 LIFE TECHNOLOGIES
    • 14.13.1 COMPANY SNAPSHOT
    • 14.13.2 PRODUCT PORTFOLIO
    • 14.13.3 RECENT DEVELOPMENT
  • 14.14 LUMINEX CORPORATION
    • 14.14.1 COMPANY SNAPSHOT
    • 14.14.2 REVENUE ANALYSIS
    • 14.14.3 PRODUCT PORTFOLIO
    • 14.14.4 RECENT DEVELOPMENT
  • 14.15 MERRIDIAN BIOSCIENCE
    • 14.15.1 COMPANY SNAPSHOT
    • 14.15.2 REVENUE ANALYSIS
    • 14.15.3 PRODUCT PORTFOLIO
    • 14.15.4 RECENT DEVELOPMENTS
  • 14.16 MYRIAD GENETICS, INC.
    • 14.16.1 COMPANY SNAPSHOT
    • 14.16.2 REVENUE ANALYSIS
    • 14.16.3 PRODUCT PORTFOLIO
    • 14.16.4 RECENT DEVELOPMENTS
  • 14.17 QIAGEN
    • 14.17.1 COMPANY SNAPSHOT
    • 14.17.2 REVENUE ANALYSIS
    • 14.17.3 PRODUCT PORTFOLIO
    • 14.17.4 RECENT DEVELOPMENTS
  • 14.18 QUIDEL CORPORATION
    • 14.18.1 COMPANY SNAPSHOT
    • 14.18.2 REVENUE ANALYSIS
    • 14.18.3 PRODUCT PORTFOLIO
    • 14.18.4 RECENT DEVELOPMENT
  • 14.19 SIEMENS HEALTHCARE GMBH
    • 14.19.1 COMPANY SNAPSHOT
    • 14.19.2 REVENUE ANALYSIS
    • 14.19.3 PRODUCT PORTFOLIO
    • 14.19.4 RECENT DEVELOPMENTS
  • 14.20 THERMO FISHER SCIENTIFIC INC
    • 14.20.1 COMPANY SNAPSHOT
    • 14.20.2 REVENUE ANALYSIS
    • 14.20.3 PRODUCT PORTFOLIO
    • 14.20.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 2 GLOBAL INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019- 2028 (USD MILLION)
  • TABLE 3 GLOBAL INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 4 GLOBAL REAGENTS AND KITS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 5 GLOBAL SERVICES AND SOFTWARES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 7 GLOBAL POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 8 GLOBAL POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 9 GLOBAL NEXT GENERATION SEQUENCING (NGS) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 10 GLOBAL CYTOGENETICS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019- 2028 (USD MILLION)
  • TABLE 11 GLOBAL CAPILLARY ELECTROPHORESIS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 12 GLOBAL INS SITU HYBRIDIZATION (ISH OR FISH) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 13 GLOBAL MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 14 GLOBAL MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 15 GLOBAL MASS SPECTROMETRY (MS) IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 16 GLOBAL CHIPS AND MICROARRAY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 17 GLOBAL OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 18 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 19 GLOBAL INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 20 GLOBAL INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 21 GLOBAL MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019- 2028 (USD MILLION)
  • TABLE 22 GLOBAL MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 23 GLOBAL BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 24 GLOBAL BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 25 GLOBAL ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 26 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 27 GLOBAL ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019- 2028 (USD MILLION)
  • TABLE 28 GLOBAL TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019- 2028 (USD MILLION)
  • TABLE 29 GLOBAL TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 30 GLOBAL PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 31 GLOBAL PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 32 GLOBAL PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019- 2028 (USD MILLION)
  • TABLE 33 GLOBAL PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 34 GLOBAL NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 35 GLOBAL NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 36 GLOBAL CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 37 GLOBAL CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 38 GLOBAL OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 39 GLOBAL OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019- 2028 (USD MILLION)
  • TABLE 40 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 41 GLOBAL CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 42 GLOBAL HOSPITAL IN MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 43 GLOBAL ACADEMICS IN MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019- 2028 (USD MILLION)
  • TABLE 44 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 45 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 46 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 47 NORTH AMERICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 48 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 49 NORTH AMERICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 50 NORTH AMERICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 NORTH AMERICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 55 NORTH AMERICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 56 NORTH AMERICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 57 NORTH AMERICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 58 NORTH AMERICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 60 NORTH AMERICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 61 NORTH AMERICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 63 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 64 U.S. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 65 U.S. INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 66 U.S. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 67 U.S. POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 68 U.S. MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 69 U.S. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 70 U.S. ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 71 U.S. ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 72 U.S. PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 73 U.S. MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 74 U.S. PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 75 U.S. TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 76 U.S. BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 77 U.S. CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 78 U.S. NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 79 U.S. INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 80 U.S. OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 81 U.S. MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 82 CANADA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 83 CANADA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 84 CANADA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 85 CANADA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 86 CANADA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 87 CANADA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 88 CANADA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 89 CANADA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 90 CANADA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 91 CANADA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 92 CANADA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 93 CANADA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 94 CANADA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 95 CANADA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 96 CANADA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 97 CANADA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 98 CANADA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 99 CANADA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 100 MEXICO MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 101 MEXICO INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 102 MEXICO MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 103 MEXICO POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 104 MEXICO MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 105 MEXICO MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 106 MEXICO ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 107 MEXICO ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 108 MEXICO PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 109 MEXICO MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 110 MEXICO PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 111 MEXICO TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 112 MEXICO BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 113 MEXICO CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 114 MEXICO NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 115 MEXICO INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 116 MEXICO OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 117 MEXICO MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 118 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 119 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 120 SOUTH AMERICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 121 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 122 SOUTH AMERICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 123 SOUTH AMERICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 124 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 125 SOUTH AMERICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 126 SOUTH AMERICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 127 SOUTH AMERICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 128 SOUTH AMERICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 129 SOUTH AMERICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 130 SOUTH AMERICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 131 SOUTH AMERICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 132 SOUTH AMERICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 133 SOUTH AMERICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 134 SOUTH AMERICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 135 SOUTH AMERICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 136 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 137 BRAZIL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 138 BRAZIL INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 139 BRAZIL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 140 BRAZIL POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 141 BRAZIL MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 142 BRAZIL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 143 BRAZIL ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 144 BRAZIL ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 145 BRAZIL PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 146 BRAZIL MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 147 BRAZIL PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 148 BRAZIL TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 149 BRAZIL BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 150 BRAZIL CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 151 BRAZIL NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 152 BRAZIL INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 153 BRAZIL OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 154 BRAZIL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 155 REST OF SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 156 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 157 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 158 ASIA-PACIFIC INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 159 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 160 ASIA-PACIFIC POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 161 ASIA-PACIFIC MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 162 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 163 ASIA-PACIFIC ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 164 ASIA-PACIFIC ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 165 ASIA-PACIFIC PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 166 ASIA-PACIFIC MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 167 ASIA-PACIFIC PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 168 ASIA-PACIFIC TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 169 ASIA-PACIFIC BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 170 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 171 ASIA-PACIFIC NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 172 ASIA-PACIFIC INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 173 ASIA-PACIFIC OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 174 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 175 CHINA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 176 CHINA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 177 CHINA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 178 CHINA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 179 CHINA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 180 CHINA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 181 CHINA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 182 CHINA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 183 CHINA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 184 CHINA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 185 CHINA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 186 CHINA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 187 CHINA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 188 CHINA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 189 CHINA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 190 CHINA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 191 CHINA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 192 CHINA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 193 JAPAN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 194 JAPAN INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 195 JAPAN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 196 JAPAN POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 197 JAPAN MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 198 JAPAN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 199 JAPAN ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 200 JAPAN ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 201 JAPAN PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 202 JAPAN MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 203 JAPAN PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 204 JAPAN TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 205 JAPAN BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 206 JAPAN CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 207 JAPAN NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 208 JAPAN INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 209 JAPAN OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 210 JAPAN MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 211 INDIA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 212 INDIA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 213 INDIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 214 INDIA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 215 INDIA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 216 INDIA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 217 INDIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 218 INDIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 219 INDIA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 220 INDIA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 221 INDIA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 222 INDIA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 223 INDIA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 224 INDIA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 225 INDIA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 226 INDIA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 227 INDIA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 228 INDIA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 229 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 230 SOUTH KOREA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 231 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 232 SOUTH KOREA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 233 SOUTH KOREA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 234 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 235 SOUTH KOREA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 236 SOUTH KOREA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 237 SOUTH KOREA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 238 SOUTH KOREA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 239 SOUTH KOREA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 240 SOUTH KOREA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 241 SOUTH KOREA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 242 SOUTH KOREA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 243 SOUTH KOREA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 244 SOUTH KOREA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 245 SOUTH KOREA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 246 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 247 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 248 AUSTRALIA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 249 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 250 AUSTRALIA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 251 AUSTRALIA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 252 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 253 AUSTRALIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 254 AUSTRALIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 255 AUSTRALIA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 256 AUSTRALIA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 257 AUSTRALIA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 258 AUSTRALIA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 259 AUSTRALIA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 260 AUSTRALIA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 261 AUSTRALIA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 262 AUSTRALIA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 263 AUSTRALIA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 264 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 265 MALAYSIA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 266 MALAYSIA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 267 MALAYSIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 268 MALAYSIA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 269 MALAYSIA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 270 MALAYSIA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 271 MALAYSIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 272 MALAYSIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 273 MALAYSIA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 274 MALAYSIA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 275 MALAYSIA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 276 MALAYSIA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 277 MALAYSIA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 278 MALAYSIA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 279 MALAYSIA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 280 MALAYSIA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 281 MALAYSIA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 282 MALAYSIA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 283 THAILAND MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 284 THAILAND INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 285 THAILAND MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 286 THAILAND POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 287 THAILAND MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 288 THAILAND MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 289 THAILAND ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 290 THAILAND ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 291 THAILAND PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 292 THAILAND MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 293 THAILAND PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 294 THAILAND TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 295 THAILAND BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 296 THAILAND CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 297 THAILAND NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 298 THAILAND INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 299 THAILAND OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 300 THAILAND MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 301 INDONESIA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 302 INDONESIA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 303 INDONESIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 304 INDONESIA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 305 INDONESIA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 306 INDONESIA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 307 INDONESIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 308 INDONESIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 309 INDONESIA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 310 INDONESIA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 311 INDONESIA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 312 INDONESIA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 313 INDONESIA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 314 INDONESIA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 315 INDONESIA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 316 INDONESIA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 317 INDONESIA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 318 INDONESIA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 319 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 320 SINGAPORE INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 321 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 322 SINGAPORE POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 323 SINGAPORE MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 324 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 325 SINGAPORE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 326 SINGAPORE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 327 SINGAPORE PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 328 SINGAPORE MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 329 SINGAPORE PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 330 SINGAPORE TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 331 SINGAPORE BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 332 SINGAPORE CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 333 SINGAPORE NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 334 SINGAPORE INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 335 SINGAPORE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 336 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 337 PHILIPPINES MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 338 PHILIPPINES INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 339 PHILIPPINES MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 340 PHILIPPINES POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 341 PHILIPPINES MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 342 PHILIPPINES MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 343 PHILIPPINES ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 344 PHILIPPINES ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 345 PHILIPPINES PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 346 PHILIPPINES MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 347 PHILIPPINES PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 348 PHILIPPINES TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 349 PHILIPPINES BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 350 PHILIPPINES CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 351 PHILIPPINES NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 352 PHILIPPINES INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 353 PHILIPPINES OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 354 PHILIPPINES MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 355 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 356 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 357 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 358 EUROPE INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 359 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 360 EUROPE POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 361 EUROPE MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 362 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 363 EUROPE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 364 EUROPE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 365 EUROPE PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 366 EUROPE MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 367 EUROPE PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 368 EUROPE TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 369 EUROPE BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 370 EUROPE CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 371 EUROPE NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 372 EUROPE INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 373 EUROPE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 374 EUROPE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 375 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 376 GERMANY INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 377 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 378 GERMANY POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 379 GERMANY MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 380 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 381 GERMANY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 382 GERMANY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 383 GERMANY PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 384 GERMANY MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 385 GERMANY PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 386 GERMANY TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 387 GERMANY BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 388 GERMANY CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 389 GERMANY NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 390 GERMANY INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 391 GERMANY OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 392 GERMANY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 393 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 394 FRANCE INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 395 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 396 FRANCE POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 397 FRANCE MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 398 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 399 FRANCE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 400 FRANCE ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 401 FRANCE PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 402 FRANCE MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 403 FRANCE PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 404 FRANCE TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 405 FRANCE BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 406 FRANCE CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 407 FRANCE NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 408 FRANCE INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 409 FRANCE OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 410 FRANCE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 411 ITALY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 412 ITALY INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 413 ITALY MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 414 ITALY POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 415 ITALY MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 416 ITALY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 417 ITALY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 418 ITALY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 419 ITALY PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 420 ITALY MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 421 ITALY PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 422 ITALY TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 423 ITALY BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 424 ITALY CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 425 ITALY NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 426 ITALY INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 427 ITALY OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 428 ITALY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 429 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 430 RUSSIA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 431 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 432 RUSSIA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 433 RUSSIA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 434 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 435 RUSSIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 436 RUSSIA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 437 RUSSIA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 438 RUSSIA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 439 RUSSIA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 440 RUSSIA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 441 RUSSIA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 442 RUSSIA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 443 RUSSIA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 444 RUSSIA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 445 RUSSIA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 446 RUSSIA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 447 U.K. MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 448 U.K. INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 449 U.K. MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 450 U.K. POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 451 U.K. MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 452 U.K. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 453 U.K. ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 454 U.K. ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 455 U.K. PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 456 U.K. MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 457 U.K. PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 458 U.K. TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 459 U.K. BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 460 U.K. CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 461 U.K. NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 462 U.K. INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 463 U.K. OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 464 U.K. MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 465 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 466 SPAIN INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 467 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 468 SPAIN POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 469 SPAIN MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 470 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 471 SPAIN ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 472 SPAIN ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 473 SPAIN PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 474 SPAIN MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 475 SPAIN PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 476 SPAIN TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 477 SPAIN BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 478 SPAIN CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 479 SPAIN NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 480 SPAIN INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 481 SPAIN OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 482 SPAIN MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 483 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 484 TURKEY INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 485 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 486 TURKEY POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 487 TURKEY MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 488 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 489 TURKEY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019- 2028 (USD MILLION)
  • TABLE 490 TURKEY ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 491 TURKEY PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 492 TURKEY MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 493 TURKEY PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 494 TURKEY TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 495 TURKEY BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 496 TURKEY CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 497 TURKEY NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 498 TURKEY INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 499 TURKEY OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 500 TURKEY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 501 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 502 SWITZERLAND INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 503 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 504 SWITZERLAND POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 505 SWITZERLAND MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 506 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 507 SWITZERLAND ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 508 SWITZERLAND ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 509 SWITZERLAND PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 510 SWITZERLAND MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 511 SWITZERLAND PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 512 SWITZERLAND TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 513 SWITZERLAND BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 514 SWITZERLAND CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 515 SWITZERLAND NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 516 SWITZERLAND INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 517 SWITZERLAND OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 518 SWITZERLAND MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 519 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 520 BELGIUM INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 521 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 522 BELGIUM POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 523 BELGIUM MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 524 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 525 BELGIUM ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 526 BELGIUM ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 527 BELGIUM PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 528 BELGIUM MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 529 BELGIUM PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 530 BELGIUM TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 531 BELGIUM BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 532 BELGIUM CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 533 BELGIUM NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 534 BELGIUM INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 535 BELGIUM OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019- 2028 (USD MILLION)
  • TABLE 536 BELGIUM MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 537 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 538 NETHERLANDS INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 539 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 540 NETHERLANDS POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 541 NETHERLANDS MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 542 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 543 NETHERLANDS ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 544 NETHERLANDS ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 545 NETHERLANDS PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 546 NETHERLANDS MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 547 NETHERLANDS PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 548 NETHERLANDS TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 549 NETHERLANDS BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 550 NETHERLANDS CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 551 NETHERLANDS NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 552 NETHERLANDS INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 553 NETHERLANDS OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 554 NETHERLANDS MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 555 REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 556 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2019- 2028 (USD MILLION)
  • TABLE 557 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019- 2028 (USD MILLION)
  • TABLE 558 MIDDLE EAST AND AFRICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 559 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 560 MIDDLE EAST AND AFRICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 561 MIDDLE EAST AND AFRICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 562 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 563 MIDDLE EAST AND AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 564 MIDDLE EAST AND AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 565 MIDDLE EAST AND AFRICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 566 MIDDLE EAST AND AFRICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 567 MIDDLE EAST AND AFRICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 568 MIDDLE EAST AND AFRICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 569 MIDDLE EAST AND AFRICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 570 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 571 MIDDLE EAST AND AFRICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 572 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 573 MIDDLE EAST AND AFRICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 574 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019- 2028 (USD MILLION)
  • TABLE 575 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 576 SOUTH AFRICA INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 577 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 578 SOUTH AFRICA POLYMERASE CHAIN REACTION (PCR)-BASED METHODS IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 579 SOUTH AFRICA MOLECULAR IMAGING IN MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
  • TABLE 580 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 581 SOUTH AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY CANCER TYPE, 2019-2028 (USD MILLION)
  • TABLE 582 SOUTH AFRICA ONCOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 583 SOUTH AFRICA PHARMACOGENOMICS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 584 SOUTH AFRICA MICROBIOLOGY IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 585 SOUTH AFRICA PRENATAL TESTS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 586 SOUTH AFRICA TISSUE TYPING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 587 SOUTH AFRICA BLOOD SCREENING IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 588 SOUTH AFRICA CARDIOVASCULAR DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 589 SOUTH AFRICA NEUROLOGICAL DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 590 SOUTH AFRICA INFECTIOUS DISEASES IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 591 SOUTH AFRICA OTHERS IN MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 592 SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 593 REST OF MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION 49
  • FIGURE 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET: DATA TRIANGULATION 52
  • FIGURE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET: DROC ANALYSIS 53
  • FIGURE 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 54
  • FIGURE 5 GLOBAL MOLECULAR DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 54
  • FIGURE 6 GLOBAL MOLECULAR DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 55
  • FIGURE 7 GLOBAL MOLECULAR DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 57
  • FIGURE 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS 58
  • FIGURE 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION 61
  • FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL MOLECULAR DIAGNOSTICS MARKET AND GROWING WITH THE HIGHEST SHARE IN THE FORECAST PERIOD OF 2021 TO 2028 62
  • FIGURE 11 THE INCREASING PREVALENCE OF INFECTIOUS DISEASES AND CANCER IS EXPECTED TO DRIVE THE GLOBAL MOLECULAR DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 63
  • FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MOLECULAR DIAGNOSTICS MARKET IN 2021 & 2028 63
  • FIGURE 13 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR MOLECULAR DIAGNOSTICS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028 64
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 76
  • FIGURE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020 90
  • FIGURE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 95
  • FIGURE 17 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2020 106
  • FIGURE 18 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2020 130
  • FIGURE 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020) 136
  • FIGURE 20 GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY REGION (2020) 137
  • FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY REGION (2021 & 2028) 137
  • FIGURE 22 GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY REGION (2020 & 2028) 138
  • FIGURE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028) 138
  • FIGURE 24 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020) 140
  • FIGURE 25 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020) 141
  • FIGURE 26 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028) 141
  • FIGURE 27 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028) 142
  • FIGURE 28 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028) 142
  • FIGURE 29 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020) 174
  • FIGURE 30 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020) 175
  • FIGURE 31 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028) 175
  • FIGURE 32 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028) 176
  • FIGURE 33 SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028) 176
  • FIGURE 34 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020) 194
  • FIGURE 35 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020) 195
  • FIGURE 36 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028) 195
  • FIGURE 37 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028) 196
  • FIGURE 38 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028) 196
  • FIGURE 39 EUROPE MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020) 283
  • FIGURE 40 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020) 284
  • FIGURE 41 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028) 284
  • FIGURE 42 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028) 285
  • FIGURE 43 EUROPE MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028) 285
  • FIGURE 44 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: SNAPSHOT (2020) 376
  • FIGURE 45 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020) 377
  • FIGURE 46 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028) 377
  • FIGURE 47 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028) 378
  • FIGURE 48 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT (2021 & 2028) 378
  • FIGURE 49 GLOBAL MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%) 396
  • FIGURE 50 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%) 397
  • FIGURE 51 EUROPE MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%) 398
  • FIGURE 52 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%) 399